GLP-1 Receptor Agonists and SGLT2 Inhibitors in Stable Kidney Transplantation: Clinical Outcomes from a Cohort of Patients with Post-Transplant Diabetes Mellitus.

J Clin Med · 2025 · PMC12787301 · PMID 41517430

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a trend toward significancep = 0.054so close (0.05 < p ≤ 0.1)

Diastolic blood pressure (DBP) also showed favorable trends, with a significant reduction in the combination therapy group (from 81.6 mmHg to 73.0 mmHg, p = 0.040), a trend toward significance in the SGLT2i group (from 76.0 mmHg to 73.3 mmHg, p = 0.054), and a non-significant reduction in the GLP-1 RA group (from 74.8 mmHg to 70.4 mmHg, p = 0.335).

also in 3,729 other papers

did not reach statistical significanceno p-value reported

Regarding glycemic control, HbA1c levels decreased across all treatment arms, though these reductions did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.